ClinicalTrials.Veeva

Menu

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

H

Humanity and Health Research Centre

Status

Enrolling

Conditions

Nonalcoholic Fatty Liver Disease
Chronic Hepatitis B

Study type

Observational

Funder types

Other

Identifiers

NCT02863757
H&H_NAFLD/CHB

Details and patient eligibility

About

The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).

Enrollment

1,500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Liver biopsy proved CHB and/or NAFLD at baseline;
  • Chinese
  • Follow-up duration>12 months

Exclusion criteria

  • Other liver diseases;
  • Secondary causes of hepatic steatosis;
  • Alcohol abuse;
  • Liver cirrhosis, cirrhosis related complications or HCC at baseline;
  • Malignancy;
  • History of liver transplantation

Trial design

1,500 participants in 3 patient groups

CHB Group
Description:
Patients with chronic hepatitis B
CHB/NAFLD Group
Description:
Patients with chronic hepatitis B and comorbid nonalcoholic fatty liver disease
NAFLD Group
Description:
Patients with nonalcoholic fatty liver disease

Trial contacts and locations

1

Loading...

Central trial contact

George Lau, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems